CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk Healthcare Auro Laboratories Ltd

Auro Laboratories Ltd

BSE 530233 AUROLAB INE292C01011
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

15 filings · 3 material · busiest 2026-07-16

What it files

Filings

15 in the window

  1. 17 August 2026

    Newspaper Publication

    Newspaper Publication

    Auro Laboratories Limited has submitted the clippings of newspaper publications of the Un-audited Financial Results for the quarter ended June 30, 2026.

    Company Update / Newspaper Publication View filing →

  2. 14 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On August 14, 2026.

    Auro Laboratories Limited has submitted the Outcome of the Board Meeting held on August 14, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  3. 14 August 2026

    Results

    Un-Audited Financial Results For The Quarter Ended June 30, 2026.

    Auro Laboratories Limited has submitted the Unaudited Financial Results for the Quarter ended June 30, 2026.

    Result / Financial Results View filing →

  4. 13 August 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Auro Laboratories Limited has submitted the Scrutinizer Report of 37th AGM held on August 11, 2026.

    AGM/EGM / AGM View filing →

  5. 11 August 2026

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Auro Laboratories Limited has submitted the Proceedings/Outcome of the 37th Annual General Meeting held on August 11, 2026.

    AGM/EGM / AGM View filing →

  6. 10 August 2026

    Board Meeting

    Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.

    Auro Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....

    Board Meeting / Board Meeting View filing →

  7. 20 July 2026

    Newspaper Publication

    Newspaper Publication

    With reference to Regulation 47 of SEBI (LODR) Regulations 2015, attached herewith newspaper cuttings of Public Notice of the 37th AGM, information on evoting and other related information.

    Company Update / Newspaper Publication View filing →

  8. 16 July 2026

    AGM / EGM

    Notice Of 37Th Annual General Meeting (AGM) Scheduled On Tuesday, August 11, 2026

    Enclosed Notice of 37th Annual General Meeting of the Company scheduled on August 11, 2026 at 11:30a.m. (IST)

    AGM/EGM / AGM View filing →

  9. 16 July 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Enclosed Annual report of the Company for the FY 2025-2026

    Others / Reg. 34 (1) Annual Report View filing →

  10. 16 July 2026

    General

    Regulation 36(1)(B) Of SEBI (LODR) Regulations, 2015

    The Letter being send to the shareholders containing the web-link of the Annual Report of the Company for the FY 2025-2026 is enclosed.

    Company Update / General View filing →

  11. 15 July 2026

    Newspaper Publication

    Newspaper Publication

    Auro Laboratories Limited has submitted the Newspaper Publication regarding intimation of 37th AGM of the Company.

    Company Update / Newspaper Publication View filing →

  12. 15 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Auro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  13. 30 June 2026

    Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Dated June 30, 2026

    Auro Laboratories Limited scheduled the Board Meeting on June 30, 2026 to transact the business matter which are attached herewith.

    Others / Outcome without intimation View filing →

  14. 30 June 2026

    Change in Management

    Change in Management

    Auro Laboratories Limited hereby approve the re-appointment of Mr. Kiran Suresh Kulkarni as a Whole Time Director.

    Company Update / Change in Management View filing →

  15. 26 June 2026

    Trading Window

    Closure of Trading Window

    Auro Laboratories Limited has informed about the Closure of Trading Window.

    Insider Trading / SAST / Closure of Trading Window View filing →